![Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep29468/MediaObjects/41598_2016_Article_BFsrep29468_Fig1_HTML.jpg)
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors | Scientific Reports
![Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases - ScienceDirect Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960076013000708-sc1.jpg)
Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases - ScienceDirect
![Steroid synthesis pathway and aromatization. Abiraterone is a novel... | Download Scientific Diagram Steroid synthesis pathway and aromatization. Abiraterone is a novel... | Download Scientific Diagram](https://www.researchgate.net/profile/Konstantin_Dedes/publication/51675707/figure/fig1/AS:393905926361091@1470925899396/Steroid-synthesis-pathway-and-aromatization-Abiraterone-is-a-novel-cytochrome-P450.png)
Steroid synthesis pathway and aromatization. Abiraterone is a novel... | Download Scientific Diagram
![CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X - CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -](https://www.cancerjournal.net/articles/2020/16/5/images/JCanResTher_2020_16_5_990_296432_f2.jpg)
CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -
![Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective - ScienceDirect Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879522617301069-gr1.jpg)
Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective - ScienceDirect
![Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation. | Semantic Scholar Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/221246dc4896637b9e595852f642fb2de12ea23e/2-Figure1-1.png)
Assessment of the potential of polyphenols as a CYP17 inhibitor free of adverse corticosteroid elevation. | Semantic Scholar
![CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X - CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -](https://www.cancerjournal.net/articles/2020/16/5/images/JCanResTher_2020_16_5_990_296432_f7.jpg)
CYP17 inhibitors improve the prognosis of metastatic castration-resistant prostate cancer patients: A meta-analysis of published trials Cao Q, Bai P, Shi D, Liao J, Shi H, Xing Y, Chen K, Zhang X -
![Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy - Njar - Translational Cancer Research Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy - Njar - Translational Cancer Research](http://cdn.amegroups.cn/journals/pbpc/files/journals/3/articles/15649/public/15649-PB4-R1.png)
Androgen receptor antagonism and impact on inhibitors of androgen synthesis in prostate cancer therapy - Njar - Translational Cancer Research
![CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrurol.2013.274/MediaObjects/41585_2014_Article_BFnrurol2013274_Fig3_HTML.jpg)
CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents | Nature Reviews Urology
![The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature. - Abstract - Europe PMC The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5046225/bin/nihms-785719-f0005.jpg)